On the contrary, as illustrated in Fig. 4, we observed a significantly lower level of IGFBP4 in cancers compared with both hyperplastic nodules and adenomas (p < 0.001), while no differences were found between the two groups of benign lesions (Fig. 4A). Here, IGFBP4 is linked to adenoma.